Skip to main content
EJNMMI Research
Fig. 3 | EJNMMI Research

Fig. 3

From: Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy

Fig. 3

Representative cases of the three patterns of FDG and FMISO SUVmax values. a CT, b FDG PET (SUVmax = 6.02). c FMISO PET (SUVmax = 1.54) image of a patient with pattern A (both low FDG and low FMISO SUVmax) who had no evidence of recurrence on follow-up at 949 days after treatment completion. d CT, e FDG PET (SUVmax = 8.73). f FMISO PET (SUVmax = 1.42) image of a patient with pattern B (high FDG SUVmax and low FMISO SUVmax) who had no evidence of recurrence on follow-up at 540 days after treatment completion. g CT, h FDG PET (SUVmax = 14.04). i FMISO PET (SUVmax = 3.36) image of a patient with pattern C (both high FDG and high FMISO SUVmax) who had recurrence on a mediastinum lymph node on follow-up CT at 195 days after treatment completion

Back to article page